Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity

Trends in Pharmacological Sciences

Volumn 27, Issue 4, 2006, Pages 190-194

  Lee, Dennis K ^a   George, Susan R ^a,b   O'Dowd, Brian F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; APELIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; HYPOPHYSIS HORMONE; INSULIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADIPOCYTE; BLOOD PRESSURE REGULATION; CYTOKINE RELEASE; FLUID INTAKE; FOOD INTAKE; HEART DISEASE; HEART FAILURE; HEART PROTECTION; HORMONE RELEASE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; INOTROPISM; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRESS;

ADIPOCYTES; ANIMALS; ANTI-OBESITY AGENTS; BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; CARRIER PROTEINS; CELL LINE; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

EID: 33645992126     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.02.006     Document Type: Review

References (62)

1. O'Dowd B.F., et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 (1993) 355-360
2. Tatemoto K., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251 (1998) 471-476
3. Masri B., et al. Apelin signalling: a promising pathway from cloning to pharmacology. Cell. Signal. 17 (2005) 415-426
4. Kleinz M.J., and Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol. Ther. 107 (2005) 198-211
5. Lee D.K., et al. Characterization of apelin, the ligand for the APJ receptor. J. Neurochem. 74 (2000) 34-41
6. Hosoya M., et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J. Biol. Chem. 275 (2000) 21061-21067
7. O'Carroll A.M., et al. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim. Biophys. Acta 1492 (2000) 72-80
8. De Mota N., et al. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 72 (2000) 400-407
9. Kawamata Y., et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim. Biophys. Acta 1538 (2001) 162-171
10. Medhurst A.D., et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J. Neurochem. 84 (2003) 1162-1172
11. Reaux A., et al. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113 (2002) 653-662
12. De Falco M., et al. Apelin expression in normal human tissues. In Vivo 16 (2002) 333-336
13. Brailoiu G.C., et al. Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci. Lett. 327 (2002) 193-197
14. Reaux A., et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J. Neurochem. 77 (2001) 1085-1096
15. Chen M.M., et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108 (2003) 1432-1439
16. Kleinz M.J., and Davenport A.P. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul. Pept. 118 (2004) 119-125
17. Vickers C., et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277 (2002) 14838-14843
18. Habata Y., et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim. Biophys. Acta 1452 (1999) 25-35
19. Masri B., et al. Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem. Biophys. Res. Commun. 290 (2002) 539-545
20. Masri B., et al. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J. 18 (2004) 1909-1911
21. Szokodi I., et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ. Res. 91 (2002) 434-440
22. Wang G., et al. Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 145 (2004) 1342-1348
23. Lee D.K., et al. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146 (2005) 231-236
24. Pals D.T., et al. An orally active inhibitor of renin. Hypertension 8 (1986) 1105-1112
25. 1 and bradykinin B2 receptors. J. Biol. Chem. 279 (2004) 7901-7908
26. 1) receptor in brain neurons. Endocrinology 139 (1998) 365-375
27. Eggena P., et al. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 22 (1993) 496-501
28. Katugampola S.D., et al. [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br. J. Pharmacol. 132 (2001) 1255-1260
29. Foldes G., et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem. Biophys. Res. Commun. 308 (2003) 480-485
30. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J. Am. Coll. Cardiol. 20 (1992) 248-254
31. Ishida J., et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J. Biol. Chem. 279 (2004) 26274-26279
32. Jia Y.X., et al. Apelin protects myocardial injury induced by isoproterenol in rats. Regul. Pept. 133 (2005) 147-154
33. Ashley E.A., et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc. Res. 65 (2005) 73-82
34. Tatemoto K., et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul. Pept. 99 (2001) 87-92
35. Cheng X., et al. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur. J. Pharmacol. 470 (2003) 171-175
36. Kagiyama S., et al. Central and peripheral cardiovascular actions of apelin in conscious rats. Regul. Pept. 125 (2005) 55-59
37. Seyedabadi M., et al. Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Auton. Neurosci. 101 (2002) 32-38
38. Sunter D., et al. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci. Lett. 353 (2003) 1-4
39. O'Shea M., et al. Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr. Neurosci. 6 (2003) 163-167
40. Taheri S., et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem. Biophys. Res. Commun. 291 (2002) 1208-1212
41. Susaki E., et al. Apelin cells in the rat stomach. Regul. Pept. 129 (2005) 37-41
42. Boucher J., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146 (2005) 1764-1771
43. Kieffer T.J., and Habener J.F. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 278 (2000) E1-E14
44. Heinonen M.V., et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul. Pept. 130 (2005) 7-13
45. Sorhede Winzell M., et al. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul. Pept. 131 (2005) 12-17
46. Wei L., et al. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul. Pept. 132 (2005) 27-32
47. Aubert J., et al. Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem. J. 328 (1997) 701-706
48. Saye J.A., et al. Angiotensinogen gene expression in 3T3-L1 cells. Am. J. Physiol. 256 (1989) C448-C451
49. Asensio C., et al. Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance. Int. J. Obes. Relat. Metab. Disord. 28 (2004) S45-S52
50. Haynes W.G. Role of leptin in obesity-related hypertension. Exp. Physiol. 90 (2005) 683-688
51. Lerman L.O., et al. Animal models of hypertension: an overview. J. Lab. Clin. Med. 146 (2005) 160-173
52. Berry M.F., et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110 (2004) II187-II193
53. Chen Y., et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol. Genomics 14 (2003) 251-260
54. Blaxall B.C., et al. Differential gene expression and genomic patient stratification following left ventricular assist device support. J. Am. Coll. Cardiol. 41 (2003) 1096-1106
55. Esposito V., et al. Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia. In Vivo 16 (2002) 337-340
56. Ellinor P.T., et al. Reduced apelin levels in lone atrial fibrillation. Eur. Heart J. 27 (2005) 222-226
57. Kasai A., et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem. Biophys. Res. Commun. 325 (2004) 395-400
58. O'Carroll A.M., et al. APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. J. Neuroendocrinol. 15 (2003) 1095-1101
59. Jaszberenyi M., et al. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129 (2004) 811-816
60. De Mota N., et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10464-10469
61. O'Carroll A.M., and Lolait S.J. Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraopric nuclei by osmotic stimuli. J. Neuroendocrinol. 15 (2003) 661-666
62. Reaux-Le Goazigo A., et al. Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 145 (2004) 4392-4400